Naval Daver, MD, a hematologist-oncologist who has led more than 100 clinical trials, predicts the next 5 years will see successful development of cellular therapies for acute myeloid leukemia.
Does being board-certified make a young oncologist practice-ready? Dr Bishal Gyawali discusses the disconnect between oncology board exams, guidelines, and real-world practice.
Full-body immersion in cold water remains the gold standard for exertional heat stroke, crucially reducing organ damage and mortality rates.
Contact allergies linked to wearables like smartwatches and earbuds are rising, with nickel and acrylates among the top allergens, a French dermatologist reports.
Treatment with dupilumab is associated with weight gain in about two thirds of adults with atopic dermatitis over 3-6 months, according to a retrospective study.
The exam shows erythematous papules and vesicles on the upper and lower extremities, along with scattered crusted lesions and hypopigmented ring lesions.
Does being board-certified make a young oncologist practice-ready? Dr Bishal Gyawali discusses the disconnect between oncology board exams, guidelines, and real-world practice.
Intravenous proton pump inhibitors are overused in patients with acute upper gastrointestinal bleeding and low-risk or no peptic ulcer disease, with only one third receiving…
Dr S. Vincent Rajkumar discusses the most promising new treatments reported for multiple stages of myeloma at this year’s ASH meeting.
Does being board-certified make a young oncologist practice-ready? Dr Bishal Gyawali discusses the disconnect between oncology board exams, guidelines, and real-world practice.
